3 Pharmaceutical Stocks to Sell Now

by Portfolio Grader | November 1, 2013 2:15 pm

This week, the ratings of three Pharmaceutical stocks on Portfolio Grader[1] are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

This week, VIVUS, Inc. (NASDAQ:VVUS[2]) falls to a D (“sell”), worse than last week’s grade of C (“hold”). VIVUS is a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. For Portfolio Grader’s specific subcategory of Equity, VVUS also gets an F. The stock price has fallen 14.1% over the past month, worse than the 1.3% decrease the Nasdaq has seen over the same period of time. As of Nov. 1, 2013, 29.8% of outstanding VIVUS, Inc. shares were held short. For a full analysis of VVUS stock, visit Portfolio Grader[3].

Cempra, Inc. (NASDAQ:CEMP[4]) experiences a ratings drop this week, going from last week’s C to a D. Cempra manufactures and markets pharmaceutical products. The stock gets F’s in Equity and Cash Flow. To get an in-depth look at CEMP, get Portfolio Grader’s complete analysis of CEMP stock[5].

Corcept Therapeutics Incorporated. (NASDAQ:CORT[6]) ratings are on the decline this week as the company earns an F (“strong sell”). Last week, it received a D (“sell”). Corcept Therapeutics engages in the discovery, development, and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders. The stock gets F’s in Equity and Cash Flow. For a full analysis of CORT stock, visit Portfolio Grader[7].

Louis Navellier’s proprietary Portfolio Grader[8] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[9].

Endnotes:
  1. Portfolio Grader: http://navelliergrowth.investorplace.com/portfolio-grader/
  2. VVUS: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=VVUS
  3. For a full analysis of VVUS stock, visit Portfolio Grader: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=VVUS
  4. CEMP: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=CEMP
  5. To get an in-depth look at CEMP, get Portfolio Grader’s complete analysis of CEMP stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=CEMP
  6. CORT: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=CORT
  7. For a full analysis of CORT stock, visit Portfolio Grader: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=CORT
  8. Portfolio Grader: http://navelliergrowth.investorplace.com/portfolio-grader/
  9. here: http://navelliergrowth.investorplace.com/portfolio-grader/

Source URL: http://investorplace.com/2013/11/3-pharmaceutical-stocks-to-sell-now-vvus-cemp-cort-28/
Short URL: http://invstplc.com/1nuToWc